Degradation of EGFR Contributes to Anti-Cancer Effects of HDAC Inhibitor in Head and Neck Cancer
dc.contributor.author | Duncan, Leslie | |
dc.contributor.author | Jensen, Caleb | |
dc.contributor.author | He, Leilei | |
dc.contributor.author | Lang, Liwei | |
dc.contributor.department | Biological Sciences, Oral Biology & Diagnostic Sciences, Georgia Cancer Center | en_US |
dc.date.accessioned | 2020-05-05T21:53:55Z | |
dc.date.available | 2020-05-05T21:53:55Z | |
dc.date.issued | 5/5/2020 | |
dc.description.abstract | This item presents the abstract for a poster presentation at the 21st Annual Phi Kappa Phi Student Research and Fine Arts Conference. | en_US |
dc.description.advisor | Yong Teng | en_US |
dc.description.sponsorship | Augusta University Provost’s Office and the Translational Research Program of the Department of Medicine | en_US |
dc.identifier.doi | http://doi.org/10.21633/issn.2380.5064/s.2020.03.02.05 | |
dc.identifier.uri | http://hdl.handle.net/10675.2/623331 | |
dc.language.iso | en_US | en_US |
dc.publisher | Augusta University Libraries | en_US |
dc.relation.ispartofseries | Volume 3, Issue 2 | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | Degradation of EGFR Contributes to Anti-Cancer Effects of HDAC Inhibitor in Head and Neck Cancer | en_US |
dc.type | Other | en_US |
refterms.dateFOA | 2020-05-05T21:53:56Z |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Duncan_vol3_issue2.pdf
- Size:
- 284 KB
- Format:
- Adobe Portable Document Format
- Description: